A significantly larger proportion of patients on IDegAsp achieved the HbA1ctarget of <7% (ADA goal) without confirmed hypoglycemia compared to those on basal insulin alone (43% vs. 25%, respectively, p < 0.01) [55]. This evidence concerns the gene INS and Hypoglycemia.